AI주식인사이트AI Stock Insight
C

이글벳

044960KOSDAQ기타 전문 도매업

51.0 / 100

Reference Date: 2026-06-10

Financial Score26.5 / 40
News Sentiment12.5 / 25
Momentum2.0 / 20
Disclosure10.0 / 15
AI Analysis: ROE significantly exceeds the industry average but Revenue metrics are weak. Plunged 21.7% over the past month, with no recent news.

Company InformationBased on 2025 Annual Report

Business Overview

Eglvet is a company specializing in the manufacturing and import of animal pharmaceuticals, leveraging the growth of the livestock industry both domestically and internationally. Its key products include nutritional supplements, antibiotics, and vaccines, with active expansion into overseas markets such as Africa, the Middle East, and Southeast Asia. The company is also exploring research opportunities in the growing pet pharmaceutical market.

Number of Employees

110people

Average Salary

48.3M KRW

Score Calculation Basis

Detailed Financial Score

PER
9.71Industry Average 13.366.5Point

Lower than industry avg (good)

PBR
0.74Industry Average 0.582.5Point

Higher than industry avg (caution)

ROE
7.85Industry Average 2.097.0Point

3.8x industry avg (excellent)

Debt Ratio
6.70Industry Average 7.874.0Point

In line with industry avg

Trend 2023~20256.5 / 10 points
Revenue Growth Rate
1.0 / 3

Avg ▲0.7% (2-year basis)

Operating Profit Growth Rate
2.5 / 3

Avg ▲13.6% (2-year basis)

ROE Trend
3.0 / 4

Avg ROE 7.5% (improving, 3yr)

Detailed News Sentiment

0 totalPositive 0Neutral 0Negative 0

Detailed Momentum

52-week position1.0Point

Near 52w low (0%, downtrend)

Current 3,030Won52-week high 4,54552-week low 3,030
1-month return0.0Point

1m -21.71% (strong drop)

Volume trend1.0Point

Volume dry-up

Detailed Disclosure

1 totalPositive 0Neutral 1Negative 0
  • Neutral분기보고서 (2026.03)2026-05-15